Inhibrx Biosciences, Inc. (INBX)
NASDAQ · Healthcare
Inhibrx Biosciences, Inc. Net Income 2023–2025
Inhibrx Biosciences, Inc. annual/quarterly net income history and growth rate from 2023 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Inhibrx Biosciences, Inc. net income for the quarter ending September 30, 2025 was -35.3 M, a 19.62% decrease year-over-year.
- Inhibrx Biosciences, Inc. net income for the twelve months ending September 30, 2025 was -151.1 M, a 108.99% decrease year-over-year.
- Inhibrx Biosciences, Inc. annual net income for 2025 was -140.1 M, a 108.30% decrease from 2024.
- Inhibrx Biosciences, Inc. annual net income for 2024 was 1.7 B, a 799.19% decrease from 2023.
- Inhibrx Biosciences, Inc. annual net income for 2023 was -241.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Inhibrx Biosciences, Inc. Net Income — FAQ
Inhibrx Biosciences, Inc. (INBX) net income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Inhibrx Biosciences, Inc.'s net income?
Inhibrx Biosciences, Inc. (INBX) reported net income of -$140M for fiscal 2025.
Where can I see INBX's net income history?
The chart and table above show Inhibrx Biosciences, Inc.'s net income by year and by quarter, including the growth rate.